1255386-16-3

1255386-16-3 structure

Name: Regorafenib D3
Chemical Name: Regorafenib D3
CAS Number: 1255386-16-3
Molecular Formula: C₂₁H₁₂D₃ClF₄N₄O₃
Molecular Weight: 485.83400
Catalog: Signaling Pathways Autophagy Autophagy
Create Date: 2018-03-26 08:00:00
Modify Date: 2026-08-06 13:19:16
Regorafenib D3 (BAY 73-4506 D3) is a deuterium labeled Regorafenib. Regorafenib is a multi-targeted receptor tyrosine kinase inhibitor[1].

Name	Regorafenib D3
Synonyms	BAY 6 D3 Regorafeniβ-d3 Regorafenib D3Q: What is Regorafenib D3 Q: What is the CAS Number of Regorafenib D3 Q: What is the storage condition of Regorafenib D3 Q: What e the applications of Regorafenib D3 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-(methyl-d3)picolinamide 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]cbamoyl}amino)-3-fluorophenoxy]-N-(2H)methylpyridine-2-cboxamide 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-(methyl-d3)-2-pyridinecarboxamide [2H3]-Regorafenib D3-Regorafenib

Description	Regorafenib D3 (BAY 73-4506 D3) is a deuterium labeled Regorafenib. Regorafenib is a multi-targeted receptor tyrosine kinase inhibitor[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Protein Tyrosine Kinase/RTK >> PDGFR Signaling Pathways >> Autophagy >> Autophagy Signaling Pathways >> MAPK/ERK Pathway >> Raf Signaling Pathways >> Protein Tyrosine Kinase/RTK >> VEGFR
References	[1]. Wilhelm SM, et al. Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity. Int J Cancer, 2011, 129(1), 245-255.